Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Rheumatoid Arthritis

Free Subscription 22.06.2026 1 Ann Rheum Dis 1 Arthritis Res Ther 1 BMC Immunol 7 Clin Rheumatol 1 Eur J Immunol 1 J Clin Invest 1 PLoS One 7 Rheumatol Int 2 Scand J Rheumatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Rheum Dis

1. FLEISCHMANN R, Nagy O, Ren J, Mysler E, et al
   Response to correspondence on 'Upadacitinib vs adalimumab in patients with rheumatoid arthritis and a prior inadequate response or intolerance to a tumour necrosis factor inhibitor: 12-week results from the randomised, double-blind, SELECT-SWITCH stud
   Ann Rheum Dis. 2026 Jun 12:S0003-4967(26)00304-3. doi: 10.1016/j.ard.2026.
   PubMed        
   
   

   
   Arthritis Res Ther

2. WILSON TM, Allen B, Harris JK, Kuhn KA, et al
   Sputum lautropia is decreased in rheumatoid arthritis-associated pulmonary fibrosis.
   Arthritis Res Ther. 2026 Jun 17. doi: 10.1186/s13075-026-03845.
   PubMed         Abstract available
   
   

   
   BMC Immunol

3. CHEN M, Fu Y, Li X, Zhou T, et al
   The clinical significance of serum complement fibroblast growth factor 21 in patients with rheumatoid arthritis.
   BMC Immunol. 2026 Jun 15. doi: 10.1186/s12865-026-00868.
   PubMed         Abstract available
   
   

   
   Clin Rheumatol

4. AL ZO'UBI M
   Awareness of rheumatoid arthritis symptoms and complications among the Jordanians.
   Clin Rheumatol. 2026 Jun 19. doi: 10.1007/s10067-026-08249.
   PubMed         Abstract available
   
   
5. YAMASHITA Y, Maeda K, Zenitani A, Saito M, et al
   Reply to: Vertebral fractures and b/tsDMARD use in rheumatoid arthritis remission: statistical imprecision and absent fracture history data limit the interpretability of the principal finding.
   Clin Rheumatol. 2026 Jun 16. doi: 10.1007/s10067-026-08225.
   PubMed        
   
   
6. CHOUDHURI B
   Vertebral fractures and b/tsDMARD use in rheumatoid arthritis remission: statistical imprecision and absent fracture history data limit the interpretability of the principal finding.
   Clin Rheumatol. 2026 Jun 16. doi: 10.1007/s10067-026-08227.
   PubMed        
   
   
7. PARREY A, Lakshman A, Ismail M, Ashraf M, et al
   Upfront low-dose biosimilar rituximab as first biologic therapy after triple csDMARD failure in seropositive rheumatoid arthritis: a prospective real-world strategy study.
   Clin Rheumatol. 2026 Jun 13. doi: 10.1007/s10067-026-08223.
   PubMed         Abstract available
   
   
8. REN T, Zhou X, Zhou E, Liu C, et al
   Elevated proportion of BST2 + CD4 + T cells: a potential biomarker for diagnosis and disease activity in Sjogren's disease.
   Clin Rheumatol. 2026;45:3459-3473.
   PubMed         Abstract available
   
   
9. ZHENG J, Xu L, Zhang J, Wei J, et al
   Macrophage 2 plays an important role in axonal lesions and vasculitis in Sjogren's syndrome complicated with peripheral neuropathy.
   Clin Rheumatol. 2026;45:3427-3439.
   PubMed         Abstract available
   
   
10. WANG H, Yan H, Yang M, Zhang Y, et al
    Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjogren's syndrome to total risk non-Hodgkin lymphoma.
    Clin Rheumatol. 2026;45:3441-3458.
    PubMed         Abstract available
    
    

    
    Eur J Immunol

11. WANG B, Bahabayi A, Huang D, Xiong Z, et al
    Identifying Negative Biomarkers of CD4 Cytotoxic T Lymphocytes via Granzyme B Exclusion Analysis.
    Eur J Immunol. 2026;56:e70213.
    PubMed         Abstract available
    
    

    
    J Clin Invest

12. WEYAND CM, Goronzy JJ
    Immune responses in aging adults.
    J Clin Invest. 2026;136:e206227.
    PubMed         Abstract available
    
    

    
    PLoS One

13. KIM S, Zhang M, Ahn JK, Hwang J, et al
    Metabolite profiling of saliva for the discrimination of Behcet's disease, Sjogren's syndrome, and recurrent aphthous stomatitis.
    PLoS One. 2026;21:e0351403.
    PubMed         Abstract available
    
    

    
    Rheumatol Int

14. ALNAIMAT F, Ayoub M, Abdelrahim B, Khalil L, et al
    Patterns of referral and histopathological interpretation of minor salivary gland biopsy in suspected Sjogren's disease: a single-center experience.
    Rheumatol Int. 2026;46:151.
    PubMed         Abstract available
    
    
15. ALKHATIB A, Al-Kofahi M, Abumuhfouz M, Elliott DRF, et al
    Hydroxychloroquine-associated cardiomyopathy with nondiagnostic noninvasive evaluation: diagnostic value of endomyocardial biopsy in a case-based review.
    Rheumatol Int. 2026;46:152.
    PubMed         Abstract available
    
    
16. BEDAIWI M
    Toward causal artificial intelligence for biologic treatment response in rheumatoid arthritis: current evidence and future directions.
    Rheumatol Int. 2026;46:149.
    PubMed         Abstract available
    
    
17. YILMAZ GC, Apaydin H, Inal RS, Gencoglu ATT, et al
    Clinical, serological, and hematological profiles according to age at diagnosis in primary Sjogren disease: a single-center cross-sectional study.
    Rheumatol Int. 2026;46:148.
    PubMed         Abstract available
    
    
18. KOLASINSKA M, Wilk M, Polak D, Siwek M, et al
    Underrecognized depressive and anxiety symptoms in inflammatory arthritis: implications for systematic screening using PHQ-9 and GAD-7.
    Rheumatol Int. 2026;46:141.
    PubMed         Abstract available
    
    
19. YERLANOVA D, Zimba O, Makhanbetkulova D, Nurmashev B, et al
    Healthcare professionals' knowledge and views on unmet needs in prevention of infectious comorbidities in pregnant women with inflammatory rheumatic diseases.
    Rheumatol Int. 2026;46:154.
    PubMed         Abstract available
    
    
20. TRUIJEN SPM, Boonen A, Ramiro S, van Onna M, et al
    Physical function in older people with rheumatoid arthritis and population controls: a cross-sectional study of self-reported and performance-based measures.
    Rheumatol Int. 2026;46:155.
    PubMed         Abstract available
    
    

    
    Scand J Rheumatol

21. MURATA K, Fujii T, Ebina K, Etani Y, et al
    Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort study.
    Scand J Rheumatol. 2026 Jun 19:1-12. doi: 10.1080/03009742.2026.2680764.
    PubMed         Abstract available
    
    
22. FENG Y, Wu S, Li D, Jiang Y, et al
    Therapeutic potential of interleukin-33 blockade in mitigating synovial inflammation and cartilage damage.
    Scand J Rheumatol. 2026;55:253-263.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum